Trametinib inhibits lymphatic vessel invasion of bone in a mouse model of Gorham-Stout disease
{{output}}
Objective: Gorham-Stout disease (GSD) is a rare lymphatic anomaly that can be caused by somatic activating mutations in KRAS. This discovery has led investigators to suggest that MEK inhibitors could be a novel treatment for GSD.... ...
